Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Introduction: Acute kidney injury (AKI) is a frequent complication of cardiopulmonary bypass (CPB). The lack of early biomarkers has impaired our ability to intervene in a timely manner. We previously showed in a small cohort of patients that plasma neutrophil gelatinase-associated lipocalin (NGAL), measured using a research enzyme-linked immunosorbent assay, is an early predictive biomarker of AKI after CPB. In this study we tested whether a point-of-care NGAL device can predict AKI after CPB in a larger cohort. Methods: First, in a cross-sectional pilot study including 40 plasma samples (NGAL range 60 to 730 ng/ml) and 12 calibration standards (NGAL range 0 to 1,925 ng/ml), NGAL measurements by enzyme-linked immunosorbent assay and by Triage® NGAL Device (Biosite Inc., San Diego, CA, USA) were highly correlated (r = 0.94). Second, in a subsequent prospective uncontrolled cohort study, 120 children undergoing CPB were enrolled. Plasma was collected at baseline and at frequent intervals for 24 hours after CPB, and analyzed for NGAL using the Triage® NGAL device. The primary outcome was AKI, which was defined as a 50% or greater increase in serum creatinine. Results: AKI developed in 45 patients (37%), but the diagnosis using serum creatinine was delayed by 2 to 3 days after CPB. In contrast, mean plasma NGAL levels increased threefold within 2 hours of CPB and remained significantly elevated for the duration of the study. By multivariate analysis, plasma NGAL at 2 hours after CPB was the most powerful independent predictor of AKI (β = 0.004, P < 0.0001). For the 2-hour plasma NGAL measurement, the area under the curve was 0.96, sensitivity was 0.84, and specificity was 0.94 for prediction of AKI using a cut-off value of 150 ng/ml. The 2 hour postoperative plasma NGAL levels strongly correlated with change in creatinine (r = 0.46, P < 0.001), duration of AKI (r = 0.57, P < 0.001), and length of hospital stay (r = 0.44, P < 0.001). The 12-hour plasma NGAL strongly correlated with mortality (r = 0.48, P = 0.004) and all measures of morbidity mentioned above. Conclusion: Accurate measurements of plasma NGAL are obtained using the point-of-care Triage® NGAL device. Plasma NGAL is an early predictive biomarker of AKI, morbidity, and mortality after pediatric CPB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The finding that NGAL was one of the most highly expressed proteins following ischaemia-reperfusion injury in kidney cells [372-374], and prognostic of kidney damage long before the more traditional marker creatinine was raised significantly, has led to considerable interest in this protein, especially as a marker of renal injury [375-389]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M. M., Ma, Q., Kelly, C., Ruff, S. M., Zahedi, K., Shao, M., Bean, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74811-x · Cited by 2,394 · cited 5×
“A major reason for the failure to find an effective treatment in patients is the paucity of early biomarkers for AKI, akin to troponins in acute myocardial disease, and hence a delay in initiating therapy [ 16 ].”
InfluentialSelf-citationMishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088027.54400.c6 · Cited by 1,749
Self-citationLassnigg, A., Schmidlin, D., Mouhieddine, M., Bachmann, L. M., Druml, W., Bauer, P., & Hiesmayr, M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130340.93930.dd · Cited by 1,348 · cited 1×
“minor degrees of postoperative AKI, as manifest by only a 0.2 to 0.3 mg/dl rise in serum creatinine from baseline, predict a significant increase in short-term mortality [ 5 ,6].”
BackgroundInfluentialIndependent Association between Acute Renal Failure and Mortality following Cardiac Surgery
Chertow, G. M., Levy, E. M., Hammermeister, K. E., Grover, F., & Daley, J. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00058-8 · Cited by 1,177 · cited 1×
“9 [4].”
Mangano, C. M., Diamondstone, L. S., Ramsay, J. G., Aggarwal, A., Herskowitz, A., & Mangano, D. T. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00005 · Cited by 1,086
A Clinical Score to Predict Acute Renal Failure after Cardiac Surgery
Thakar, C. V., Arrigain, S., Worley, S., Yared, J.-P., & Paganini, E. P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004040331 · Cited by 1,067 · cited 1×
“Clinical investigations have identified several risk factors associated with the development of AKI after CPB, the majority related to either impaired renal perfusion or decreased renal reserve, and have resulted in the development of clinical scoring systems for the prediction of AKI [10-13].”
BackgroundAcute Kidney Injury Associated with Cardiac Surgery
Rosner, M. H., & Okusa, M. D. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240605 · Cited by 1,063 · cited 1×
“Acute kidney injury (AKI), previously referred to as acute renal failure, is a frequent and serious complication encountered in 30% to 50% of subjects after CPB [2,3].”
BackgroundUpdate on Mechanisms of Ischemic Acute Kidney Injury
Devarajan, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010017 · Cited by 1,026 · cited 1×
“sciences have illuminated the pathogenesis of AKI and have paved the way to successful therapeutic approaches in animal models [14].”
BackgroundSelf-citationMori, K., Lee, H. T., Rapoport, D., Drexler, I. R., Foster, K., Yang, J., Schmidt-Ott, K. M., Chen, X., Li, J. Y., Weiss, S., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23056 · Cited by 954
Self-citationDual Action of Neutrophil Gelatinase–Associated Lipocalin
Schmidt-Ott, K. M., Mori, K., Li, J. Y., Kalandadze, A., Cohen, D. J., Devarajan, P., & Barasch, J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080882 · Cited by 772 · cited 2×
“Gene expression studies in AKI have also shown rapid upregulation of NGAL mRNA in the thick ascending limb of Henle's loop and the collecting ducts, with resultant synthesis of NGAL protein in the distal nephron (the renal pool) and secretion into the urine where it comprises the major fraction of urinary NGAL [30,31].”
BackgroundSelf-citationCohn, L. H. (2003) · Cited by 667
Mehta, R. H., Grab, J. D., O’Brien, S. M., Bridges, C. R., Gammie, J. S., Haan, C. K., Ferguson, T. B., & Peterson, E. D. (2006) · Circulation · doi:10.1161/circulationaha.106.635573 · Cited by 596
Amelioration of Ischemic Acute Renal Injury by Neutrophil Gelatinase-Associated Lipocalin
Mishra, J., Mori, K., Ma, Q., Kelly, C., Yang, J., Mitsnefes, M., Barasch, J., & Devarajan, P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145013.44578.45 · Cited by 536
Self-citationMishra, J., Mori, K., Ma, Q., Kelly, C., Barasch, J., & Devarajan, P. (2004) · American Journal of Nephrology · doi:10.1159/000078452 · Cited by 535 · cited 2×
“NGAL protein was also markedly induced in kidney tubule cells, and easily detected in the plasma and urine in animal models of ischemic and nephrotoxic AKI [ 18-22 ].”
BackgroundSelf-citationWijeysundera, D. N., Karkouti, K., Dupuis, J.-Y., Rao, V., Chan, C. T., Granton, J. T., & Beattie, W. S. (2007) · JAMA · doi:10.1001/jama.297.16.1801 · Cited by 469 · cited 1×
“Clinical investigations have identified several risk factors associated with the development of AKI after CPB, the majority related to either impaired renal perfusion or decreased renal reserve, and have resulted in the development of clinical scoring systems for the prediction of AKI [10-13].”
BackgroundLoef, B. G., Epema, A. H., Smilde, T. D., Henning, R. H., Ebels, T., Navis, G., & Stegeman, C. A. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2003100875 · Cited by 466 · cited 1×
“AKI after cardiac surgery is also associated with a number of adverse outcomes, including prolonged intensive care and hospital stay, dialysis dependency, diminished quality of life, and increased long-term mortality [ 7-9 ].”
BackgroundDifferential gene expression following early renal ischemia/reperfusion
Supavekin, S., Zhang, W., Kucherlapati, R., Kaskel, F. J., Moore, L. C., & Devarajan, P. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00928.x · Cited by 465 · cited 3×
“We identified neutrophil gelatinase-associated lipocalin (NGAL) as one of the most upregulated genes in the kidney soon after ischemic injury [18-20].”
BackgroundSelf-citationNGAL is an early predictive biomarker of contrast-induced nephropathy in children
Hirsch, R., Dent, C., Pfriem, H., Allen, J., Beekman, R. H., Ma, Q., Dastrala, S., Bennett, M., Mitsnefes, M., & Devarajan, P. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0601-4 · Cited by 454 · cited 3×
“For example, plasma NGAL is also an early, sensitive, specific, and predictive biomarker of AKI after contrast administration [26].”
BackgroundMethodResultSelf-citationKidney NGAL is a novel early marker of acute injury following transplantation
Mishra, J., Ma, Q., Kelly, C., Mitsnefes, M., Mori, K., Barasch, J., & Devarajan, P. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0055-0 · Cited by 354 · cited 2×
“The expression of NGAL protein was also dramatically increased in kidney tubules of humans with ischemic, septic, and post-transplant AKI [23,24].”
BackgroundSelf-citationThakar, C. V., Worley, S., Arrigain, S., Yared, J.-P., & Paganini, E. P. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00177.x · Cited by 318 · cited 1×
“3 mg/dl rise in serum creatinine from baseline, predict a significant increase in short-term mortality [5,6].”
BackgroundLipocalins as biochemical markers of disease
Xu, S., & Venge, P. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00163-1 · Cited by 285
Emerging Biomarkers of Acute Kidney Injury
Devarajan, P. (2007) · Contributions to Nephrology · doi:10.1159/000102085 · Cited by 276
Self-citationPharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven’t Worked and What Is on the Horizon
Jo, S. K., Rosner, M. H., & Okusa, M. D. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03280906 · Cited by 252 · cited 2×
“In current clinical practice, the 'gold standard' for identification and classification of AKI is dependent on serial serum creatinine measurements [17], which are especially unreliable during acute changes in kidney function [15,16].”
BackgroundIdentification of a New Acute Phase Protein
Liu, Q., & Nilsen-Hamilton, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22565 · Cited by 249 · cited 1×
“from the fact that NGAL is a known acute phase reactant and may be released from neutrophils, macrophages, and other immune cells [32].”
BackgroundNeutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia
Schmidt-Ott, K. M., Mori, K., Kalandadze, A., Li, J.-Y., Paragas, N., Nicholas, T., Devarajan, P., & Barasch, J. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000232886.81142.58 · Cited by 237
Self-citationDevarajan, P., Mishra, J., Supavekin, S., Patterson, L. T., & Steven Potter, S. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.09.012 · Cited by 229 · cited 3×
“We identified neutrophil gelatinase-associated lipocalin (NGAL) as one of the most upregulated genes in the kidney soon after ischemic injury [18-20].”
BackgroundSelf-citationImpact of renal insufficiency on short- and long-term outcomes after cardiac surgery
Lok, C. E., Austin, P. C., Wang, H., & Tu, J. V. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.12.042 · Cited by 140
Cardiopulmonary Bypass-Associated Acute Kidney Injury: A Pigment Nephropathy?
Haase, M., Haase‐Fielitz, A., Bagshaw, S. M., Ronco, C., & Bellomo, R. (2007) · Contributions to nephrology · doi:10.1159/000102125 · Cited by 111 · cited 2×
“Acute kidney injury (AKI), previously referred to as acute renal failure, is a frequent and serious complication encountered in 30% to 50% of subjects after CPB [2,3].”
BackgroundPediatric acute kidney injury: it’s time for real progress
Goldstein, S. L. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0173-8 · Cited by 47 · cited 1×
“These patients comprise an ideal and important population for the study of AKI biomarkers, because they do not exhibit common comorbid variables that complicate similar studies in adults, such as diabetes, hypertension, atherosclerosis, and nephrotoxin use [33].”
BackgroundAcute Renal Failure and Cardiac Surgery
Mehta, R. L. (2004) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110954 · Cited by 38 · cited 1×
“Clinical investigations have identified several risk factors associated with the development of AKI after CPB, the majority related to either impaired renal perfusion or decreased renal reserve, and have resulted in the development of clinical scoring systems for the prediction of AKI [10-13].”
BackgroundThe early biomarker of acute kidney injury: in search of the Holy Grail
Honoré, P. M., Joannès-Boyau, O., & Boer, W. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0766-0 · Cited by 32 · cited 1×
“The availability of a validated point-of-care tool for NGAL measurements could revolutionize renal diagnostics in critical care situations [27].”
MethodOne step forward in the early detection of acute renal failure
Herget-Rosenthal, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74787-5 · Cited by 28 · cited 1×
“It has been suggested that a clinically acceptable assay for diagnosing AKI should be a robust system that can measure the appropriate analyte rapidly day or night [ 28 ].”
Background
Cited by
Haase, M., Bellomo, R., Devarajan, P., Schlattmann, P., & Haase-Fielitz, A. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.07.020 · Cited by 1,339
“Of enrolled patients, 70% were rom the United States.(13-16,18,19,22,23,25,26) Alhough there were 2 studies from China(20,28) and from South America,(27) the generalizability of GAL value needs further local investigation nd validation.”
BackgroundMethodSelf-citationCardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment
Wang, Y., & Bellomo, R. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.119 · Cited by 767
Zuk, A., & Bonventre, J. V. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-050214-013407 · Cited by 739
Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery
Parikh, C. R., Coca, S. G., Thiessen-Philbrook, H., Shlipak, M. G., Koyner, J. L., Wang, Z., Edelstein, C. L., Devarajan, P., Patel, U. D., Zappitelli, M., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121302 · Cited by 754
Self-citationThe Outcome of Neutrophil Gelatinase-Associated Lipocalin-Positive Subclinical Acute Kidney Injury
Haase, M., Devarajan, P., Haase-Fielitz, A., Bellomo, R., Cruz, D. N., Wagener, G., Krawczeski, C. D., Koyner, J. L., Murray, P., Zappitelli, M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.051 · Cited by 684
“It was iscovered with unbiased transcriptomic approaches (8,9); it s rapidly induced and released from the injured distal ephron in experimental models and human disease 5,9,10); its urine and plasma concentrations increase proortionally to severity and duration of renal injury (9,11,12); ts concentration rapidly decr…”
BackgroundSelf-citation
Metadata
- Authors
- Dent, C. L., Ma, Q., Dastrala, S., Bennett, M., Mitsnefes, M. M., Barasch, J., & Devarajan, P.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Columbia University (US)
- Corresponding author
- Devarajan, Prasad
- Venue
- Critical Care
- Published
- 2007-12-10
- Volume
- 11
- Issue
- 6
- Pages
- R127-R127
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2246223
- OpenAlex
- W2035397803
- Cited by
- 483
- References
- 33
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 13 · 2022: 11 · 2021: 18 · 2020: 8 · 2019: 15 · 2018: 18 · 2017: 20 · 2016: 36 · 2015: 46 · 2014: 43 · 2013: 47 · 2012: 49
- FWCI
- 22.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Cincinnati Children's Hospital Medical Center
- National Institutes of Health (DK52612)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK070163, P50DK052612, R01DK053289)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- neutrophil gelatinase-associated lipocalin, acute kidney injury, pediatric cardiac surgery, cardiopulmonary bypass, point-of-care biomarkers, early prediction of AKI, serum creatinine, postoperative morbidity and mortality, length of hospital stay, renal function monitoring, pediatric congenital heart disease, postoperative renal complications, biomarker validation
- MeSH terms
- Lipocalin-2, Acute-Phase Proteins, Child, Child, Preschool, Cross-Sectional Studies, Female, Cardiac Surgical Procedures, Humans, Male, Morbidity, Mortality, Pilot Projects, Predictive Value of Tests, Prospective Studies, Proto-Oncogene Proteins, Cohort Studies, Biomarkers, Point-of-Care Systems, Lipocalins, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.